Literature DB >> 1336243

Animal immunodeficiency viruses.

H Egberink1, M C Horzinek.   

Abstract

Feline immunodeficiency virus (FIV) has morphological, physical and biochemical characteristics similar to human immunodeficiency virus (HIV), the cause of AIDS in man. However, it is antigenically and genetically distinct from HIV; an antigenic relatedness with equine infectious anaemia virus has been demonstrated. FIV has been molecularly cloned and sequenced. Diagnostic tests are commercially available and attempts at preparing inactivated, subunit and molecularly engineered vaccines are being made in different laboratories. During FIV infection a transient primary illness can be recognized, with fever, neutropenia and lymphadenopathy. After a long period of clinical normalcy a secondary stage is distinguished with signs of an immunodeficiency-like syndrome. The incubation period for this stage can be as long as 5 years, during which gradual impairment of immune function develops. Many FIV-infected cats are presented for the first time showing vague signs of illness: recurrent fevers, emaciation, lack of appetite, lymphadenopathy, anaemia, leucopenia and behavioural changes. Later, the predominant clinical signs observed are chronic stomatitis/gingivitis, enteritis, upper respiratory tract infections, and infections of the skin. Neoplasias, neurological, immunological and haematological disorder are seen in a smaller proportion. The immunodeficiency-like syndrome is progressive over a period of months to years. Concomitant infection with feline leukaemia virus has been shown to accelerate the progression of disease. In vitro, phenotypic mixing between FIV and an endogenous feline oncovirus (RD114) has been demonstrated which leads to a broadening of the cell spectrum of the lentivirus. Bovine immunodeficiency virus (BIV) has been isolated only once, and all attempts to obtain additional isolates have failed; it has been recovered from the leucocytes of cattle with persistent lymphocytosis, lymphadenopathy, lesions in the central nervous system, progressive weakness and emaciation. As with the feline representative, BIV also was found to possess a lentivirus morphology and to encode a reverse transcriptase with Mg++ preference; it replicates and induces syncytia in a variety of embryonic bovine tissues in vitro. Antigenic analyses have demonstrated a conservation of epitopes between the major core protein of BIV and HIV. The original isolate has been molecularly cloned and sequenced. Besides the three large open reading frames (ORFs) comprising the gag, pol, and env genes common to all replication-competent retroviruses, five additional small ORFs were found. Numerous point mutations and deletions were found, mostly in the env-encoding ORF. These data suggest that, within a single virus isolate, BIV displays extensive genomic variation.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1336243      PMCID: PMC7117276          DOI: 10.1016/0378-1135(92)90059-3

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  70 in total

1.  A VIRUS-LIKE PARTICLE ASSOCIATED WITH LEUKEMIA (LYMPHOSARCOMA).

Authors:  W F JARRETT; E M CRAWFORD; W B MARTIN; F DAVIE
Journal:  Nature       Date:  1964-05-09       Impact factor: 49.962

Review 2.  Clinical overview of feline immunodeficiency virus.

Authors:  N C Pedersen; J E Barlough
Journal:  J Am Vet Med Assoc       Date:  1991-11-15       Impact factor: 1.936

3.  Feline immunodeficiency virus: A commentary.

Authors:  R C Povey; G J Hawkins
Journal:  Can Vet J       Date:  1989-07       Impact factor: 1.008

4.  CD4-independent infection of human neural cells by human immunodeficiency virus type 1.

Authors:  J M Harouse; C Kunsch; H T Hartle; M A Laughlin; J A Hoxie; B Wigdahl; F Gonzalez-Scarano
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

5.  Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection.

Authors:  N C Pedersen; M Torten; B Rideout; E Sparger; T Tonachini; P A Luciw; C Ackley; N Levy; J Yamamoto
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

6.  Myelitis in a cat infected with Toxoplasma gondii and feline immunodeficiency virus.

Authors:  J R Heidel; J P Dubey; L L Blythe; L L Walker; J R Duimstra; J S Jordan
Journal:  J Am Vet Med Assoc       Date:  1990-01-15       Impact factor: 1.936

7.  Altered mitogen response of peripheral blood lymphocytes in different stages of feline immunodeficiency virus infection.

Authors:  A Taniguchi; T Ishida; A Konno; T Washizu; I Tomoda
Journal:  Nihon Juigaku Zasshi       Date:  1990-06

8.  Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats.

Authors:  J K Yamamoto; E Sparger; E W Ho; P R Andersen; T P O'Connor; C P Mandell; L Lowenstine; R Munn; N C Pedersen
Journal:  Am J Vet Res       Date:  1988-08       Impact factor: 1.156

9.  Susceptibility of human peripheral blood dendritic cells to infection by human immunodeficiency virus.

Authors:  S Patterson; S C Knight
Journal:  J Gen Virol       Date:  1987-04       Impact factor: 3.891

10.  A serologic survey of Oklahoma cats for antibodies to feline immunodeficiency virus, coronavirus, and Toxoplasma gondii and for antigen to feline leukemia virus.

Authors:  S J Rodgers; C A Baldwin
Journal:  J Vet Diagn Invest       Date:  1990-07       Impact factor: 1.279

View more
  7 in total

1.  Prevention of immunodeficiency virus induced CD4+ T-cell depletion by prior infection with a non-pathogenic virus.

Authors:  Julie A Terwee; Jennifer K Carlson; Wendy S Sprague; Kerry S Sondgeroth; Sarah B Shropshire; Jennifer L Troyer; Sue VandeWoude
Journal:  Virology       Date:  2008-05-22       Impact factor: 3.616

2.  Expression of feline immunodeficiency virus gag and env precursor proteins in Spodoptera frugiperda cells and their use in immunodiagnosis.

Authors:  E J Verschoor; A L van Vliet; H F Egberink; W Hesselink; M C Horzinek; A de Ronde
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

3.  Binding of Tat to TAR and recruitment of positive transcription elongation factor b occur independently in bovine immunodeficiency virus.

Authors:  M Barboric; R Taube; N Nekrep; K Fujinaga; B M Peterlin
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

4.  Isolation of caprine arthritis encephalitis virus from goats in Mexico.

Authors:  M Daltabuit Test; A de la Concha-Bermejillo; L E Espinosa; E Loza Rubio; A Aguilar Setién
Journal:  Can J Vet Res       Date:  1999-07       Impact factor: 1.310

5.  Nucleotide sequence of feline immunodeficiency virus: classification of Japanese isolates into two subtypes which are distinct from non-Japanese subtypes.

Authors:  S Kakinuma; K Motokawa; T Hohdatsu; J K Yamamoto; H Koyama; H Hashimoto
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

Review 6.  The inside out of lentiviral vectors.

Authors:  Stéphanie Durand; Andrea Cimarelli
Journal:  Viruses       Date:  2011-02-14       Impact factor: 5.818

Review 7.  Important mammalian veterinary viral immunodiseases and their control.

Authors:  J R Patel; J G M Heldens; T Bakonyi; M Rusvai
Journal:  Vaccine       Date:  2012-01-17       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.